54.26 USD
↗ 1.42 (2.69%)AT CLOSE (11:59 AM EDT)
Moderna, Inc. Common Stock
MRNANASDAQ • USD
54.26
↗ 0.00 (0.01%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
54.26
↗ 0.00 (0.01%)
Market: CLOSED
Open?$53.76
High?$55.20
Low?$53.26
Prev. Close?$52.84
Volume?4.8M
Avg. Volume?7.5M
VWAP?$53.98
Rel. Volume?0.64x
Bid / Ask
Bid?$54.15 × 500
Ask?$54.38 × 200
Spread?$0.23
Midpoint?$54.27
Valuation & Ratios
Market Cap?21.5B
Shares Out?394.9M
Float?346.8M
Float %?88.8%
P/E Ratio?N/A
P/B Ratio?2.49
EPS?-$7.12
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?3.29Strong
Quick Ratio?3.22Strong
Cash Ratio?1.31Strong
Debt/Equity?0.07Low
ValuationFAIRLY VALUED
Score67/100
P/E?N/A▾
P/B?2.49CHEAP▾
P/S?11.07HIGH▾
P/FCF?N/A▾
EV/EBITDA?-6.8CHEAP▾
EV/Sales?10.05HIGH▾
Returns & Efficiency
ROE?-32.6%WEAK▾
ROA?-22.9%WEAK▾
Cash Flow & Enterprise
FCF?$-2065000000
Enterprise Value?$19.5B
Related Companies
Loading...
News
Profile
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Employees
4.7K
Market Cap
21.0B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2018-12-07
Address
325 BINNEY STREET
CAMBRIDGE, MA 02142
Phone: (617) 714-6500
CAMBRIDGE, MA 02142
Phone: (617) 714-6500